C07C 279/30
Derivatives of guanidine, i.e. compounds containing the group [image cpc-sch-c07c-0970.gif], the singly-bound
Official title: having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
C07C279/30 (Derivatives of guanidine, i.e. compounds containing the group [image cpc-sch-c07c-0970.gif], the singly-bound) appears on 64 US grants and 38 published applications in this corpus.
Search patents in C07C- Granted patents
- 64
- Published applications
- 38
- Assignees
- 39
- Inventors
- 144
- Latest grant
- 2 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 4 | 0 |
| 1996 | 4 | 0 |
| 1997 | 5 | 0 |
| 1998 | 3 | 0 |
| 1999 | 4 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 2 |
| 2003 | 3 | 4 |
| 2004 | 3 | 4 |
| 2005 | 0 | 2 |
| 2006 | 3 | 0 |
| 2007 | 1 | 2 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 1 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 5 |
| 2018 | 4 | 3 |
| 2019 | 4 | 4 |
| 2020 | 3 | 1 |
| 2021 | 0 | 1 |
| 2022 | 1 | 2 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 3 | 1 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compounds and compositions for intracellular delivery of therapeutic agents2 Sep 2025US 12,404,232 B2ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents10 Jun 2025US 12,324,859 B2ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents1 Apr 2025US 12,263,248 B2ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents26 Nov 2024US 12,151,995 B2ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents11 Jan 2022US 11,220,476 B2ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents19 Mar 2026US 2026/0078082 A1ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents12 Mar 2026US 2026/0069549 A1ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents17 Jul 2025US 2025/0228777 A1ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents18 Apr 2024US 2024/0124388 A1ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents29 Dec 2022US 2022/0409536 A1ModernaTX, Inc.
Most cited
By later US patents
- Compounds and compositions for intracellular delivery of therapeutic agents143US 9,868,691 B2ModernaTX, Inc. · 2018
- Compounds and compositions for intracellular delivery of therapeutic agents88US 10,857,105 B2MordernaTX, Inc. · 2020
- Guanidine derivatives, their production and insecticides88US 5,034,404 ATakeda Chemical Industries, Ltd. · 1991
- Compounds and compositions for intracellular delivery of therapeutic agents62US 9,868,692 B2ModernaTX, Inc. · 2018
- Amino acids and peptides having modified C-terminals and modified N-terminals57US 5,654,451 AMagainin Pharmaceuticals Inc. · 1997